MedTrace Logo

Effect of Omeprazole on PK of Fluzoparib in Healthy Male Subjects

NCT04108676 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2022-07-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the Effect of Omeprazole on the Pharmacokinetics of Fluzoparib in Healthy male Adults.

Conditions

  • Advanced Solid Tumor

Interventions

DRUG

Fluzoparib

PARP inhibitor

DRUG

Omeprazole

proton pump inhibitor

Sponsors & Collaborators

  • The Third Xiangya Hospital of Central South University

    collaborator OTHER

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Guoping Yang, PhD · The Third Xiangya Hospital of Central South University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-07
Primary Completion
2019-09-18
Completion
2019-11-18

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04108676 on ClinicalTrials.gov